Mutagenicity of DNA adducts derived from ethylene oxide exposure in the pSP189 shuttle vector replicated in human Ad293 cells

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 678, Issue 2, 2009, Pages 129-137

  Tompkins, Elaine M ^a   McLuckie, Keith I E ^a   Jones, Donald J L ^a   Farmer, Peter B ^a   Brown, Karen ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

DNA adduct; Ethylene oxide; Mutation; supF

Indexed keywords

DNA; ETHYLENE OXIDE; GUANINE DERIVATIVE; NUCLEOTIDE; SOLVENT;

ARTICLE; BASE PAIRING; BIOLOGY; CELL DIVISION; CHEMICAL REACTION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DNA ADDUCT; EMBRYO; EXPERIMENT; GENE; GENE MUTATION; HUMAN; HUMAN CELL; KIDNEY CELL; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MUTAGENICITY; MUTATION RATE; NUCLEIC ACID BASE SUBSTITUTION; PLASMID; PRIORITY JOURNAL; SHUTTLE VECTOR; SUPF GENE;

BASE SEQUENCE; CELL LINE; DNA ADDUCTS; DNA DAMAGE; DOSE-RESPONSE RELATIONSHIP, DRUG; ETHYLENE OXIDE; GENES, SUPPRESSOR; GENETIC VECTORS; HUMANS; MOLECULAR SEQUENCE DATA; MUTAGENS; RNA, TRANSFER;

EID: 69449088524     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrgentox.2009.05.011     Document Type: Article

References (46)

1. NTP, 10th Report on Carcinogens, Research Triangle Park, NC, US Department of Health and Human Services, Public Health Service, National Institutes of Health, National Toxicology Program, 2002.
2. Hogstedt C., Malmqvist N., and Wadman B. Leukaemia in workers exposed to ethylene oxide. J. Am. Med. Assoc. 241 (1979) 1132-1133
3. Hogstedt C., Rohlen O., Berndtsson B., Axelson O., and Ehrenberg L. A cohort study of mortality and cancer incidence in ethylene oxide production workers. Br. J. Ind. Med. 36 (1979) 276-280
4. Hogstedt C., Aringer L., and Gustavsson A. Epidemiologic support for ethylene-oxide as a cancer-causing agent. J. Am. Med. Assoc. 255 (1986) 1575-1578
5. Teta M.J., Sielken R.L., and Valdez-Flores C. Ethylene oxide cancer risk assessment based on epidemiological data: application of revised regulatory guidelines. Risk Anal. 19 (1999) 1135-1155
6. Coggon D., Harris E.C., Poole J., and Palmer K.T. Mortality of British workers exposed to ethylene oxide: extended follow up of a British cohort. Occup. Environ. Med. 61 (2004) 358-362
7. Steenland K., Stayner J., and Deddens J. Mortality analyses in a cohort of 18235 ethylene oxide exposed workers: follow up extended from 1987 to 1998. Occup. Environ. Med. 61 (2004) 2-7
8. Hogstedt B., Gullberg B., Hedner K., Kolnig A.M., Mitelman F., Skerfving S., and Widegren B. Chromosome aberrations and micronuclei in bone marrow cells and peripheral blood lymphocytes in humans exposed to ethylene oxide. Hereditas 98 (1983) 105-113
9. IARC. 1,3-Butadiene, ethylene oxide and vinyl halides (vinyl fluoride, vinyl chloride and vinyl bromide). IARC Monographs on the Evaluation of Carcinogenic Risks to Humans vol. 97 (2008), International Agency for Research on Cancer, Lyon, France pp. 185-309
10. Walker V.E., Fennell T.R., Upton P.B., Skopek T.R., Prevost V., Shuker D.E.G., and Swenberg J.A. Molecular dosimetry of ethylene oxide: formation and persistence of N7-(2-hydroxyethyl)guanine in DNA following repeated exposure of rats and mice. Cancer Res. 52 (1992) 4328-4334
11. Segerbäck D. Reaction products in hemoglobin and DNA after in vitro treatment with ethylene oxide and N-(2-hydroxyethyl)-N-nitrosourea. Carcinogenesis 11 (1990) 307-312
12. Li F., Segal A., and Solomon J.J. In vitro reaction of ethylene oxide with DNA and characterization of DNA adducts. Chem. Biol. Interact. 83 (1992) 35-54
13. Recio L., Donner M., Abernethy D., Pluta L., Steen A.M., Wong B.A., James A., and Preston R.J. In vivo mutagenicity and mutation spectrum in the bone marrow and testes of B6C3F1 lacI transgenic mice following inhalation exposure to ethylene oxide. Mutagenesis 19 (2004) 215-222
14. Sisk S.C., Pluta L.J., Meyer K.G., Wong B.C., and Recio L. Assessment of the in vivo mutagenicity of ethylene oxide in the tissues of B6C3F1 lacI transgenic mice following inhalation exposure. Mutat. Res. 391 (1997) 153-164
15. Walker V.E., Sisk S.C., Upton P.B., Wong B.A., and Recio L. In vivo mutagenicity of ethylene oxide at the hprt locus in T-lymphocytes of B6C3F1 lacI transgenic mice following inhalation exposure. Mutat. Res. 392 (1997) 211-222
16. Hong H.H.L., Houle C.D., Ton T.V.T., and Sills R.C. K-ras mutations in lung tumors and tumors from other organs are consistent with a common mechanism of ethylene oxide tumorigenesis in the B6C3F1 mouse. Toxicol. Pathol. 35 (2007) 81-85
17. Takeshita M., Chang C.H., Johnson F., Will S., and Grollman A.P. Oligonucleotides containing synthetic abasic sites: model substrates for DNA-polymerases and apurinic apyrimidinic endonucleases. J. Biol. Chem. 262 (1987) 10171-10179
18. Loeb L.A., and Preston B.D. Mutagenesis by apurinic apyrimidinic sites. Ann. Rev. Gen. 20 (1986) 201-230
19. Rusyn I., Asakura S., Li Y., Kosyk O., Koc H., Nakamura J., Upton P.B., and Swenberg J.A. Effects of ethylene oxide and ethylene inhalation of DNA adducts, apurinic/apyrimidinic sites and expression of base excision DNA repair genes in rat brain, spleen and liver. DNA Repair 4 (2005) 1099-1110
20. Tompkins E.M., Jones D.J.L., Lamb J.H., Marsden D.A., Farmer P.B., and Brown K. Simultaneous detection of five different 2-hydroxyethyl DNA adducts formed by ethylene oxide exposure, using a high-performance liquid chromatography/electrospray ionisation tandem mass spectrometry assay. Rapid Commun. Mass Spectrom. 22 (2008) 19-28
21. McLuckie K.I.E., Routledge M.N., Brown K., Gaskell M., Farmer P.B., Roberts G.C.K., and Martin E.A. DNA adducts formed from 4-hydroxytamoxifen are more mutagenic than those formed by α-acetoxytamoxifen in a shuttle vector target gene replicated in human Ad293 cells. Biochemistry 41 (2002) 8899-8906
22. Gaskell M., McLuckie K.I.E., and Farmer P.B. Comparison of the mutagenic activity of the benzene metabolites, hydroquinone and para-benzoquinone in the supF forward mutation assay: a role for minor DNA adducts formed from hydroquinone in benzene mutagenicity. Mutat. Res. 554 (2004) 387-398
23. Cariello N.F., Piegorsch W.W., Adams W.T., and Skopek T.R. Computer program for the analysis of mutational spectra: application to p53 mutations. Carcinogenesis 15 (1994) 2281-2285
24. Routledge M.N., McLuckie K.I.E., Jones G.D.D., Farmer P.B., and Martin E.A. Presence of benzo[a]pyrene diol epoxide adducts in target DNA leads to an increase in UV-induced DNA single strand breaks and supF gene mutations. Carcinogenesis 22 (2001) 1231-1238
25. Kim M.Y., Zhou X., Delaney J.C., Taghizadeh K., Dedon P.C., Essigmann J.M., and Wogan G.N. AlkB influences the chloroacetaldehyde-induced mutation spectra and toxicity in the supF shuttle vector. Chem. Res. Toxicol. 20 (2007) 1075-1083
26. Lee D.H., and Pfeifer G.P. Translesion synthesis of 7,8-dihydro-8-oxo-2′deoxyguanosine by DNA polymerase eta in vivo. Mutat. Res. 641 (2008) 19-26
27. Upton D.C., Wang X., Blans P., Perrino F.W., Fishbein J.C., and Akman S.A. Mutagenesis by exocyclic alkylamino purine adducts in Escherichia coli. Mutat. Res. 599 (2006) 1-10
28. Liapis E., McLuckie K.I.E., Lewis P.D., Farmer P.B., and Brown K. Mutagenicity of tamoxifen DNA adducts in human endometrial cells and in silico prediction of p53 mutation hotspots. Nucleic Acids Res. 36 (2008) 5933-5945
29. McLuckie K.I.E., Lamb J.H., Sandhu J.K., Pearson H.L., Brown K., Farmer P.B., and Jones D.J.L. Development of a novel site-specific mutagenesis assay using MALDI-ToF MS (SSMA-MS). Nucleic Acids Res. 34 (2006) e150
30. Kim S., Pfeifer G.P., and Besaratinia A. Lack of mutagenicity in acrolein-induced DNA adducts in mouse and human cells. Cancer Res. 67 (2007) 11640-11647
31. Niedernhofer L.J., Daniels J.S., Rouzer C.A., Greene R.E., and Marnett L.J. Malondialdehyde a product of lipid peroxidation, is mutagenic in human cells. J. Biol. Chem. 278 (2003) 31426-31433
32. Yamane A., Shinmura K., Sunaga N., Saitoh T., Yamaguchi S., Shinmura Y., Yoshimura K., Murakami H., Nojima Y., Kohno T., and Yokota J. Suppressive activities of OGG1 and MYH proteins against G:C to T:A mutations caused by 8-hydroxyguanine but not by benzo[a]pyrene diol epoxide in human cells in vivo. Carcinogenesis 24 (2003) 1031-1037
33. Doak S.H., Jenkins G.J.S., Johnson G.E., Quick E., Parry E.M., and Parry J.M. Mechanistic influences for mutation induction curves after exposure to DNA-reactive carcinogens. Cancer Res. 67 (2007) 3904-3911
34. Beranek D.T. Distribution of methyl and ethyl adducts following alkylation with monofunctional alkylating agents. Mutat. Res. 231 (1990) 11-30
35. Bhanot O.S., Singh U.S., and Soloman J.J. The role of 3-hydroxyethyldeoxyuridine in mutagenesis by ethylene oxide. J. Biol. Chem. 269 (1994) 30056-30064
36. Vodicka P., Koskinen M., Arand M., Oesch F., and Hemminki K. Spectrum of styrene-induced DNA adducts: the relationship to other biomarkers and prospects in human biomonitoring. Mutat. Res. 511 (2002) 239-254
37. Bhanot O.S., Grevatt P.C., Donahue J.M., Gabrielides C.N., and Solomon J.J. Incorporation of dA opposite N3-ethylthymidine terminates in vitro DNA-synthesis. Biochemistry 29 (1990) 10357-10364
38. Grevatt P.C., Donahue J.M., and Bhanot O.S. The role of N3-ethyldeoxythymidine in, mutagenesis and cytotoxicity by ethylating agents. J. Biol. Chem. 266 (1991) 1269-1275
39. Bhanot O.S., and Ray A. The in vivo mutagenic frequency and specificity of O6-methylguanine in phi-X174 replicative form DNA. Proc. Natl. Acad. Sci. U.S.A. 83 (1986) 7348-7352
40. 4-ethano-2′-deoxycytidine, and 3-(2-hydroxyethyl)-2′-deoxyuridine. Chem. Res. Toxicol. 8 (1995) 157-163
41. Kokoska R.J., McCulloch S.D., and Kunkel T.A. The efficiency and specificity of apurinic/apyrimidinic site bypass by human DNA polymerase η and Sulfolobus solfataricus Dpo4. J. Biol. Chem. 278 (2003) 50537-50545
42. Simonelli V., Narciso L., Dogliotti E., and Fortini P. Base excision repair intermediates are mutagenic in mammalian cells. Nucleic Acids Res. 33 (2005) 4404-4411
43. Avkin S., Adar S., Blander G., and Livneh Z. Quantitative measurement of translesion replication in human cells: evidence for bypass of abasic sites by a replicative DNA polymerase. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 3764-3769
44. Bastlova T., Andersson B., Lambert B., and Kolman A. Molecular analysis of ethylene oxide-induced mutations at the HPRT locus in human diploid fibroblasts. Mutat. Res. 287 (1993) 283-292
45. Ádám B., Bárdon H., and Ádány R. Increased genotoxic susceptibility of breast epithelial cells to ethylene oxide. Mutat. Res. 585 (2005) 120-126
46. W.K. Lutz, R.W. Lutz, Statistical model to estimate a threshold dose and its confidence limits for the analysis of sublinear dose-response relationships, exemplified for mutagenicity data, Mutat. Res., in this issue.